Polyrizon Announces $4 Mln Registered Direct Offering And Private Placement

Polyrizon Ltd. (PLRZ) announced definitive agreements with a single institutional investor for a registered direct offering and a concurrent private placement, aimed at raising aggregate gross proceeds (amount not provided in the excerpt). The financing is expected to support the company’s development-stage biotech plans but typically implies dilution risk for existing shareholders. Overall, the news is a modest, stock-specific negative catalyst due to capital-raise overhang without deal-size detail.